サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1455380

ライフサイエンスにおける人工知能の世界市場レポート 2024

Artificial Intelligence In Life Sciences Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ライフサイエンスにおける人工知能の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ライフサイエンスにおける人工知能の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には23.6%の年間平均成長率（CAGR）で68億2,000万米ドルに成長すると予想されます。予測期間で予想される成長は、リアルタイムの遠隔患者モニタリング（RPM）システムへの関心の高まり、創薬におけるAIの需要の高まり、医療画像解析におけるAIの採用の増加など、さまざまな要因に関連している可能性があります。予測期間中に予想される注目すべき動向には、戦略的パートナーシップ、製品提供の革新、技術の進歩、投資の増加、進行中の研究開発イニシアチブが含まれます。

リアルタイムの遠隔患者モニタリング（RPM）システムに対する関心の高まりにより、近い将来、ライフサイエンスにおける人工知能市場の拡大が促進されると考えられます。テクノロジー主導のヘルスケアソリューションを特徴とする遠隔患者監視システムは、従来のヘルスケア環境を超えて患者の健康を監視することを目的としています。ライフサイエンス分野では、AIは遠隔患者モニタリングにおいて極めて重要な役割を果たし、プロアクティブなヘルスケア管理を促進する継続的でパーソナライズされたデータ駆動型の洞察を提供します。米国に本拠を置くデジタルヘルスケア企業Vivalinkが実施した調査によると、臨床医による遠隔患者モニタリング（RPM）の導入が注目すべき急増を示し、2021年の20%から2022年の81%に増加し、305%もの大幅な増加となっています。その結果、リアルタイムの遠隔患者モニタリング（RPM）システムへの関心の高まりが、ライフサイエンスにおける人工知能市場の成長を牽引しています。

ライフサイエンスにおける人工知能市場に取り組む大手企業は、市場での地位を維持するために、創薬ソフトウェアに代表される技術進歩を特徴とする革新的な製品に注力しています。創薬ソフトウェアは、創薬プロセス中に製薬およびバイオテクノロジー分野の研究者を支援するために調整されたコンピュータープログラムとアプリケーションで構成されます。 2023年 12月、ドイツに本拠を置く科学技術企業メルクは、革新的な創薬ソフトウェアであるAIDDISONを発表しました。 AIDDISONは、この種のものとしては初と位置づけられており、生成AI、機械学習、コンピューター支援医薬品設計を活用して、仮想分子設計と現実世界の製造可能性を統合しています。AIDDISONは、無毒性や溶解性といった本質的な特性を考慮し、膨大な可能性の中から医薬品候補を特定することに優れています。バーチャルな分子設計と現実の製造可能性のギャップを埋めるそのユニークな能力は、ライフサイエンス分野における人工知能の注目すべき用途を強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のライフサイエンスにおける人工知能市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ソフトウェア
  • ハードウェア
  • サービス
  • 世界のライフサイエンスにおける人工知能市場、展開別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • オンプレミス
  • クラウドベース
  • 世界のライフサイエンスにおける人工知能市場、アプリケーション別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 創薬
  • 医学的診断
  • バイオテクノロジー
  • クリニカルトレイル
  • 精密かつ個別化された医療
  • 患者のモニタリング

第7章 地域および国の分析

  • 世界のライフサイエンスにおける人工知能市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のライフサイエンスにおける人工知能市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ライフサイエンスにおける人工知能市場の競合情勢
  • ライフサイエンスにおける人工知能市場企業プロファイル
    • Google LLC
    • Microsoft Corporation
    • Intel Corporation
    • IBM Corporation
    • Medtronic PLC

第31章 その他の主要および革新的な企業

  • Nvidia Corporation
  • Novo Nordisk A/S
  • Siemens Healthineers AG
  • Philips Healthcare
  • Babylon Healthcare Services Ltd.
  • Komodo Health Inc.
  • Modernizing Medicine Inc.
  • Viz.ai Inc.
  • Butterfly Network Inc.
  • Augmedix
  • AiCure LLC
  • HealthTap Inc.
  • Welltok Inc.
  • Enlitic Inc.
  • PathAI Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r16381

Artificial intelligence (AI) in life sciences involves the application of AI technologies and techniques across various domains within the life sciences industry. The integration of AI aims to enhance and expedite processes, improve decision-making, and extract valuable insights from complex data sets.

The primary components of artificial intelligence in life sciences include software, hardware, and services. The software employs AI algorithms to analyze extensive chemical databases, predicting the likelihood of specific molecules binding to target receptors, thereby accelerating the drug discovery process. These software applications can be deployed through on-premises and cloud-based models and find applications in various domains such as drug discovery, medical diagnosis, biotechnology, clinical trials, precision and personalized medicine, and patient monitoring.

The artificial intelligence in life sciences market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in life sciences market statistics, including artificial intelligence in life sciences industry global market size, regional shares, competitors with artificial intelligence in life sciences market share, detailed artificial intelligence in life science market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence in life sciences industry. This artificial intelligence in life sciences market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in life sciences market size has grown exponentially in recent years. It will grow from $2.35 billion in 2023 to $2.92 billion in 2024 at a compound annual growth rate (CAGR) of 24.2%. The growth observed during the historical period can be attributed to several factors, including the increasing number of clinical trials, a rising adoption of AI in the domain of research and development (R&D), and a heightened emphasis on the development of precision medicine and personalized drugs.

The artificial intelligence in life sciences market size is expected to see exponential growth in the next few years. It will grow to $6.82 billion in 2028 at a compound annual growth rate (CAGR) of 23.6%. The anticipated growth in the forecast period can be linked to various factors, including the escalating interest in real-time remote patient monitoring (RPM) systems, a growing demand for AI in drug discovery, and an increased adoption of AI in medical imaging analysis. Noteworthy trends expected in the forecast period encompass strategic partnerships, innovations in product offerings, technological advancements, increased investments, and ongoing research and development initiatives.

The growing interest in real-time remote patient monitoring (RPM) systems is set to drive the expansion of artificial intelligence in the life sciences market in the foreseeable future. Remote patient monitoring systems, characterized by technology-driven healthcare solutions, aim to monitor patients' health beyond traditional healthcare settings. In the life sciences domain, AI plays a pivotal role in remote patient monitoring, offering continuous, personalized, and data-driven insights that facilitate proactive healthcare management. A survey conducted by Vivalink, a US-based digital healthcare company, revealed a noteworthy surge in clinicians' adoption of remote patient monitoring (RPM), growing from 20% in 2021 to 81% in 2022, representing a substantial 305% increase. Consequently, the rising interest in real-time remote patient monitoring (RPM) systems is steering the growth of artificial intelligence in the life sciences market.

Leading companies operating in the artificial intelligence in the life sciences market are directing their efforts towards innovative products featuring technological advancements, exemplified by drug discovery software, to maintain their market standing. Drug discovery software comprises computer programs and applications tailored to assist researchers in the pharmaceutical and biotechnology sectors during the drug discovery process. In December 2023, Merck, a Germany-based science and technology company, unveiled AIDDISON, a revolutionary drug discovery software. Positioned as the first of its kind, AIDDISON integrates virtual molecule design with real-world manufacturability, leveraging generative AI, machine learning, and computer-aided drug design. AIDDISON excels in identifying drug candidates from a vast array of possibilities, considering essential properties such as non-toxicity and solubility. Its unique capability to bridge the gap between virtual molecule design and real-world manufacturability underscores a notable application of artificial intelligence in the life sciences sector.

In June 2023, Verix, a US-based company specializing in pharma commercial operations, completed the acquisition of Start-up.AI for an undisclosed sum. Verix's strategic move to acquire Start-up.AI aims to fortify its capabilities in artificial intelligence (AI) and machine learning (ML) within the pharmaceutical commercial operations sector. Start-up.ai, based in Israel, is a provider of an AI-driven commercial optimization platform, enhancing Verix's prowess in life science AI capabilities.

Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.AI Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.

North America was the largest region in the Artificial Intelligence In Life Sciences market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in the life sciences market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence (AI) in the life sciences market consists of revenues earned by entities by private analytics, AI-driven clinical trial services, and real-world evidence services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the life sciences market also consists of sales of high-performance computing (HPC) clusters, edge computing devices, and IoT devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Life Sciences Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in life sciences market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in life sciences ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in life sciences market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Offering: Software; Hardware; Services
  • 2) By Deployment: On-Premises; Cloud-Based
  • 3) By Application: Drug Discovery; Medical Diagnosis; Biotechnology; Clinical Trails; Precision and Personalized Medicine; Patient Monitoring
  • Companies Mentioned: Google LLC; Microsoft Corporation; Intel Corporation; IBM Corporation; Medtronic PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Life Sciences Market Characteristics

3. Artificial Intelligence In Life Sciences Market Trends And Strategies

4. Artificial Intelligence In Life Sciences Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Artificial Intelligence In Life Sciences Market Size and Growth

  • 5.1. Global Artificial Intelligence In Life Sciences Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Artificial Intelligence In Life Sciences Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Artificial Intelligence In Life Sciences Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Artificial Intelligence In Life Sciences Market Segmentation

  • 6.1. Global Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.3. Global Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery
  • Medical Diagnosis
  • Biotechnology
  • Clinical Trails
  • Precision and Personalized Medicine
  • Patient Monitoring

7. Artificial Intelligence In Life Sciences Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence In Life Sciences Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Artificial Intelligence In Life Sciences Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Artificial Intelligence In Life Sciences Market

  • 8.1. Asia-Pacific Artificial Intelligence In Life Sciences Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Artificial Intelligence In Life Sciences Market

  • 9.1. China Artificial Intelligence In Life Sciences Market Overview
  • 9.2. China Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Artificial Intelligence In Life Sciences Market

  • 10.1. India Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Artificial Intelligence In Life Sciences Market

  • 11.1. Japan Artificial Intelligence In Life Sciences Market Overview
  • 11.2. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Artificial Intelligence In Life Sciences Market

  • 12.1. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Artificial Intelligence In Life Sciences Market

  • 13.1. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Artificial Intelligence In Life Sciences Market

  • 14.1. South Korea Artificial Intelligence In Life Sciences Market Overview
  • 14.2. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Artificial Intelligence In Life Sciences Market

  • 15.1. Western Europe Artificial Intelligence In Life Sciences Market Overview
  • 15.2. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Artificial Intelligence In Life Sciences Market

  • 16.1. UK Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Artificial Intelligence In Life Sciences Market

  • 17.1. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Artificial Intelligence In Life Sciences Market

  • 18.1. France Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Artificial Intelligence In Life Sciences Market

  • 19.1. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Artificial Intelligence In Life Sciences Market

  • 20.1. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Artificial Intelligence In Life Sciences Market

  • 21.1. Eastern Europe Artificial Intelligence In Life Sciences Market Overview
  • 21.2. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Artificial Intelligence In Life Sciences Market

  • 22.1. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Artificial Intelligence In Life Sciences Market

  • 23.1. North America Artificial Intelligence In Life Sciences Market Overview
  • 23.2. North America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Artificial Intelligence In Life Sciences Market

  • 24.1. USA Artificial Intelligence In Life Sciences Market Overview
  • 24.2. USA Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Artificial Intelligence In Life Sciences Market

  • 25.1. Canada Artificial Intelligence In Life Sciences Market Overview
  • 25.2. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Artificial Intelligence In Life Sciences Market

  • 26.1. South America Artificial Intelligence In Life Sciences Market Overview
  • 26.2. South America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Artificial Intelligence In Life Sciences Market

  • 27.1. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Artificial Intelligence In Life Sciences Market

  • 28.1. Middle East Artificial Intelligence In Life Sciences Market Overview
  • 28.2. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Artificial Intelligence In Life Sciences Market

  • 29.1. Africa Artificial Intelligence In Life Sciences Market Overview
  • 29.2. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Artificial Intelligence In Life Sciences Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence In Life Sciences Market Competitive Landscape
  • 30.2. Artificial Intelligence In Life Sciences Market Company Profiles
    • 30.2.1. Google LLC
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Microsoft Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Intel Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. IBM Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Medtronic PLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Artificial Intelligence In Life Sciences Market Other Major And Innovative Companies

  • 31.1. Nvidia Corporation
  • 31.2. Novo Nordisk A/S
  • 31.3. Siemens Healthineers AG
  • 31.4. Philips Healthcare
  • 31.5. Babylon Healthcare Services Ltd.
  • 31.6. Komodo Health Inc.
  • 31.7. Modernizing Medicine Inc.
  • 31.8. Viz.ai Inc.
  • 31.9. Butterfly Network Inc.
  • 31.10. Augmedix
  • 31.11. AiCure LLC
  • 31.12. HealthTap Inc.
  • 31.13. Welltok Inc.
  • 31.14. Enlitic Inc.
  • 31.15. PathAI Inc.

32. Global Artificial Intelligence In Life Sciences Market Competitive Benchmarking

33. Global Artificial Intelligence In Life Sciences Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Intelligence In Life Sciences Market

35. Artificial Intelligence In Life Sciences Market Future Outlook and Potential Analysis

  • 35.1 Artificial Intelligence In Life Sciences Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence In Life Sciences Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence In Life Sciences Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer